Stock Events

Stock Events

Z Squared 

$0.010400
19
+$0.00+13.04%Friday 20:00
-$0.00-8.65%Friday 23:56Pre-market

Statistics

Day High
0.0123
Day Low
0.0123
52W High
0.045
52W Low
0.0074
Volume
4,425,580
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Sep 2Expected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
-1
-0.93
-0.87
-0.8
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2005
2018
2019
2020
2021
2022
0Revenue
-74.88MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap179.47B
Gilead Sciences is a biopharmaceutical company that competes in the development of innovative therapies, similar to Coeptis Therapeutics' focus on novel treatments.
AMGEN
AMGN
Mkt Cap217.9B
Amgen is a biotech firm that develops therapeutic solutions in various disease areas, competing with Coeptis Therapeutics in the biopharmaceutical space.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol Myers Squibb is involved in discovering, developing, and delivering innovative medicines, making it a competitor in the pharmaceutical and biotech industry.
Merck
MRK
Mkt Cap356.01B
Merck operates in the pharmaceutical sector, focusing on innovative drug development and directly competing with companies like Coeptis Therapeutics.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a global biopharmaceutical company with a wide range of products and research areas, overlapping with Coeptis Therapeutics' interests.
Novartis
NVS
Mkt Cap268B
Novartis is a healthcare company that engages in the research, development, and marketing of healthcare products, competing in the same space as Coeptis Therapeutics.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie is a research-based biopharmaceutical company, its diverse range of pharmaceutical products places it in competition with Coeptis Therapeutics.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a leader in research-focused healthcare with strengths in pharmaceuticals and diagnostics, making it a competitor in the healthcare sector.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson is a comprehensive healthcare firm that competes across various segments, including pharmaceuticals, which overlaps with Coeptis Therapeutics' operations.
Regeneron Pharmaceuticals
REGN
Mkt Cap75.69B
Regeneron Pharmaceuticals is a leading biotechnology company that develops and commercializes medicines for serious medical conditions, competing in the biopharmaceutical field.

About

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a Vy-Gen drug product for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; and CD38-Diagnostic, an in vitro screening tool to provide the ability to pre-determine which cancer patients are most likely to benefit from targeted anti-CD38 monoclonal antibodies therapies. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics Holdings, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.
Show More
CEO
Mr. David Mehalick
Employees
4
Country
United States
ISIN
US19207A1161

Listings

F
DE
AQ4.F
XNAS
US
ZSQR
BOATS
BOATS
COEP.BOATS

0 Comments

Share your thoughts

FAQs

What is Z Squared stock price today?▼
The current price of COEPW is $0.01 USD — it has increased by +13.04% in the past 24 hours. Watch Z Squared stock price performance more closely on the chart.
What is Z Squared stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Z Squared stocks are traded under the ticker COEPW.
Is Z Squared stock price growing?▼
COEPW stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Z Squared has showed a -53.98% decrease.
What is Z Squared revenue for the last year?▼
Z Squared revenue for the last year amounts to 0 USD.
What is Z Squared net income for the last year?▼
COEPW net income for the last year is -74.88M USD.
How many employees does Z Squared have?▼
As of October 16, 2026, the company has 4 employees.
In which sector is Z Squared located?▼
Z Squared operates in the Health & Wellness sector.
When did Z Squared complete a stock split?▼
Z Squared has not had any recent stock splits.
Where is Z Squared headquartered?▼
Z Squared is headquartered in Wexford, United States.